Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication.

Owens CM, Mawhinney C, Grenier JM, Altmeyer R, Lee MS, Borisy AA, Lehár J, Johansen LM.

Mol Syst Biol. 2010 Jun 8;6:375. doi: 10.1038/msb.2010.32.

2.

A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication.

Zuck P, Murray EM, Stec E, Grobler JA, Simon AJ, Strulovici B, Inglese J, Flores OA, Ferrer M.

Anal Biochem. 2004 Nov 15;334(2):344-55.

PMID:
15494142
3.

Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.

Huang P, Goff DA, Huang Q, Martinez A, Xu X, Crowder S, Issakani SD, Anderson E, Sheng N, Achacoso P, Yen A, Kinsella T, Darwish IS, Kolluri R, Hong H, Qu K, Stauffer E, Goldstein E, Singh R, Payan DG, Lu HH.

Antimicrob Agents Chemother. 2008 Apr;52(4):1419-29. doi: 10.1128/AAC.00525-07. Epub 2008 Jan 28.

4.

Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.

Okuse C, Rinaudo JA, Farrar K, Wells F, Korba BE.

Antiviral Res. 2005 Jan;65(1):23-34.

PMID:
15652968
5.

Replication of the hepatitis C virus in cell culture.

Bartenschlager R, Kaul A, Sparacio S.

Antiviral Res. 2003 Oct;60(2):91-102. Review.

PMID:
14638404
6.
7.

The hepatitis C virus life cycle as a target for new antiviral therapies.

Pawlotsky JM, Chevaliez S, McHutchison JG.

Gastroenterology. 2007 May;132(5):1979-98. Review.

PMID:
17484890
8.
9.

Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway.

Kim K, Kim KH, Kim HY, Cho HK, Sakamoto N, Cheong J.

FEBS Lett. 2010 Feb 19;584(4):707-12. doi: 10.1016/j.febslet.2009.12.019. Epub 2009 Dec 17.

11.

Hijacking hepatitis C viral replication with a non-coding replicative RNA.

Bitard J, Chognard G, Dumas E, Rumi J, Masante C, Mahias K, Astier-Gin T, Ventura M.

Antiviral Res. 2010 Jul;87(1):9-15. doi: 10.1016/j.antiviral.2010.04.003. Epub 2010 Apr 9.

PMID:
20382185
13.

Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.

Roy S, Gupta N, Subramanian N, Mondal T, Banerjea AC, Das S.

J Gen Virol. 2008 Jul;89(Pt 7):1579-86. doi: 10.1099/vir.0.83650-0.

PMID:
18559927
14.

Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor.

Goto K, Watashi K, Inoue D, Hijikata M, Shimotohno K.

Cancer Sci. 2009 Oct;100(10):1943-50. doi: 10.1111/j.1349-7006.2009.01263.x. Epub 2009 Jun 26.

16.

Selective inhibitors of hepatitis C virus replication.

Neyts J.

Antiviral Res. 2006 Sep;71(2-3):363-71. Epub 2006 Jun 23. Review.

PMID:
16843538
17.

Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.

Jia Y, Wei L, Jiang D, Wang J, Cong X, Fei R.

J Gastroenterol Hepatol. 2007 Aug;22(8):1278-85. Epub 2007 Jun 12.

PMID:
17565587
18.

Advances in genomic research on hepatitis C virus with a useful tool, replicon system.

Nakamura M, Saito H, Hibi T.

Keio J Med. 2008 Jun;57(2):75-83. Review.

19.

Specific inhibition of hepatitis C virus replication by cyclosporin A.

Nakagawa M, Sakamoto N, Enomoto N, Tanabe Y, Kanazawa N, Koyama T, Kurosaki M, Maekawa S, Yamashiro T, Chen CH, Itsui Y, Kakinuma S, Watanabe M.

Biochem Biophys Res Commun. 2004 Jan 2;313(1):42-7.

PMID:
14672695
20.

Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.

Henry SD, Metselaar HJ, Lonsdale RC, Kok A, Haagmans BL, Tilanus HW, van der Laan LJ.

Gastroenterology. 2006 Nov;131(5):1452-62. Epub 2006 Aug 14.

PMID:
17101321

Supplemental Content

Support Center